Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 18.0 | 44 | ||||
| RA1869 | IKK16 | 2.0 | uM | 1 | CTACK | 16.5 | 60 | ||||
| N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 12.0 | 54 | ||||
| N2759 | IKK16 | 2.0 | uM | 1 | CTACK | 19.0 | 59 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 14.5 | 54 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | CTACK | 14.0 | 61 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | CTACK | 15.0 | 71 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | CTACK | 14.5 | 48 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | CTACK | 16.5 | 56 | ||||
| RA1869 | 1 | CTACK | 16.0 | 47 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | CTACK | 14.0 | 48 | ||||
| N2759 | 1 | CTACK | 12.0 | 53 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | CTACK | 13.0 | 37 | ||||
| RA1931 | 1 | CTACK | 15.0 | 48 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | CTACK | 16.0 | 42 | ||||
| N2586 | 1 | CTACK | 16.0 | 52 | |||||||
| 0 | CTACK | 17.0 | 39 | ||||||||
| 0 | CTACK | 15.0 | 59 | ||||||||
| 0 | CTACK | 14.0 | 57 | ||||||||
| 0 | CTACK | 14.5 | 38 | ||||||||
| 0 | CTACK | 16.0 | 41 | ||||||||
| 0 | CTACK | 20.0 | 33 | ||||||||
| RA2159 | 2 | CTACK | 20.5 | 38 | |||||||
| N2645 | 2 | CTACK | 20.0 | 74 | |||||||
| RA2708 | 2 | CTACK | 17.0 | 42 |